Form D · Pharmaceuticals
Nemus
Costa Mesa, CA · CIK 0001611294
Offering snapshot reported Oct 20, 2014 · SEC filing
- Reported sold
- $455K Offering amount: $455K
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 7, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 20, 2014 | Initial | $455,100 | No comparison | 18 | SEC filing |
| Jun 27, 2014 | Initial | $1,486,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-226811
Source: Form D, filed Oct 20, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Elizabeth Berecz | Executive |
| John Hollister | Director, Executive |
| Reg Lapham | Promoter |
| Cosmas Lykos | Director, Executive |
| Jerry Mc Laughlin | Director |
| Brian Murphy | Executive |
| David Skibinski | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
650 Town Center Drive Suite 620
Costa Mesa, CA, 92626
Costa Mesa, CA, 92626